期刊論文 Publications
期刊論文 Publications
Pei JC*, Luo DZ*, Gau SS, Chang CY, Lai WS. Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients with Schizophrenia. Front Psychiatry. 2021 Oct 1;12:742058. doi: 10.3389/fpsyt.2021.742058. eCollection 2021. (SSCI)
Chang CY*, Luo DZ*, Pei JC, Kuo MC, Hsieh YC, Lai WS. Not Just a Bystander: The Emerging Role of Astrocytes and Research Tools in Studying Cognitive Dysfunctions in Schizophrenia. Int J Mol Sci. 2021 May 19;22(10):5343. doi: 10.3390/ijms22105343. (SCI)
Luo DZ*, Chang CY*, Huang TR, Vincent Studer, Wang TW, Lai WS. Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models. Scientific Reports. 2020 Jan 20;10(1):647. doi: 10.1038/s41598-019-57340-8. (SCI)
Pei JC, Hung WL, Lin BX, Shih MH, Lu LY, Luo DZ, Tai HC, Studer V, Min MY, Lai WS. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia. J Psychopharmacol. 2019 Oct;33(10):1288-1302. doi: 10.1177/0269881119856558. (SCI)
Huang CH, Pei JC, Luo DZ, Chen C, Chen YW, Lai WS. Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia. Front Behav Neurosci. 2015 Jan 29;8:455. doi: 10.3389/fnbeh.2014.00455. (SCI)
賴文崧， 羅達中 。為絕症尋找仙丹 共濟失調症新藥研發與篩檢測試平台。人文與社會科學簡訊。109 年 3 月， 21 卷 2 期。
*: co-first author